What happened
Engineered living materials for controlled drug delivery: design strategies, therapeutic applications and quality-by-design considerations for clinical translation
SourceBiomaterials and Living Medicine for PharmaceuticspublicationBiotech
Engineered living materials for controlled drug delivery: design strategies, therapeutic applications and quality-by-design considerations for clinical translation
Publication signal: Engineered living materials for controlled drug delivery: design strategies, therapeutic applications and quality-by-design considerations for clinical translation
Factual summary
Why it matters
Recent source-backed research output for AISci Stage A browsing.
SourceBiomaterials and Living Medicine for PharmaceuticsLimitations
AISci rank score does not assess scientific quality or citation impact.
SourceBiomaterials and Living Medicine for PharmaceuticsLinked output
Engineered living materials for controlled drug delivery: design strategies, therapeutic applications and quality-by-design considerations for clinical translationpaperPeople
No reviewed person relationship is attached to this event.
Organizations
No reviewed organization relationship is attached to this event.
Topics
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
Clinical and Regulatory
Controlled AISci Stage A topic for Clinical and Regulatory.
Engineered living materials for controlled drug delivery: design strategies, therapeutic applications and quality-by-design considerations for clinical translation
Engineered living materials for controlled drug delivery: design strategies, therapeutic applications and quality-by-design considerations for clinical translation
Timeline
- publicationEngineered living materials for controlled drug delivery: design strategies, therapeutic applications and quality-by-design considerations for clinical translation